News

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
TANZANIA is among countries expected to benefit from the upcoming rollout of injectable lenacapavir for HIV prevention, following a landmark recommendation by the World Health Organization (WHO).
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...
The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...
HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...
Pharma giant Gilead Sciences agreed to pay hundreds of millions of dollars to state health insurance programs after admitting ...
The World Health Organization has released new guidelines which, for the first time, recommend the use of an injectable form ...
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
The World Health Organization just announced this week that they want all countries to help make a breakthrough HIV drug reach people as quickly and safely as possible. The drug's nickname is "Len," a ...
Gilead Sciences (GILD) stock slips as the company agrees to pay $202M to settle allegations that its HIV drug promotion ...